Fundraising Fox
/Companies
Sign in

Transgenomic

Acquired

Omaha, US · Delaware corporation · 1 known investors

Find your way into Transgenomic

Sign up to see every warm intro you have to Transgenomic

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Transgenomic team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Acquired by Precipio Diagnostics, LLC June 2017 · terms undisclosed · source ↗

Transgenomic was a molecular diagnostics company that developed genetic testing platforms like WAVE and ICE COLD-PCR for cancer and inherited disease detection, and ran CLIA-certified labs.

Biotech

Founders & leadership

PK
Paul KinnonExecutive
LF
Leon F. RichardsExecutive
AP
ANTONIUS P SCHUHExecutive
CJ
CRAIG J TUTTLEDIRECTOR, PRESIDENT AND CEO
CM
CHAD M RICHARDSCHIEF COMMERCIAL OFFICER
BL
BRETT L FREVERTCFO
MP
Mark P. ColonneseExecutive

Board

RM
Robert M. PatzigBoard director
DL
Doit L. Koppler, IIBoard director
MA
Michael A. LutherBoard director
JD
John D. ThompsonBoard director
RS
Rodney S. MarkinBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$52.7M disclosed across 12 of 13 rounds · 2011–2017

▶$810.8KraisedNov 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ilan DanieliExecutive Officer, Director
  • Jeff CossmanDirector
  • David CohenDirector
  • Mark RimerDirector
  • Doug FisherDirector
  • Michael LutherDirector
  • Samuel RiccitelliDirector
  • Carl IbergerExecutive Officer
Offering amount
$810.8K
Amount sold
$810.8K
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedJul 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samuel D. RiccitelliDirector
  • Michael A. LutherDirector
  • Robert M. PatzigDirector
  • Carl IbergerExecutive Officer
  • Ilan DanieliExecutive Officer, Director
  • Mark RimerDirector
Offering amount
$8.3M
Amount sold
$8.3M
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$800KraisedJul 2017 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert M. PatzigDirector
  • Carl IbergerExecutive Officer
  • Michael A. LutherDirector
  • Mark RimerDirector
  • Samuel D. RiccitelliDirector
  • Ilan DanieliExecutive Officer, Director
Offering amount
$800K
Amount sold
$800K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJul 2017 · 45 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert M. PatzigDirector
  • Ilan DanieliExecutive Officer, Director
  • Samuel D. RiccitelliDirector
  • Mark RimerDirector
  • Michael A. LutherDirector
  • Carl IbergerExecutive Officer
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedJul 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl IbergerExecutive Officer
  • Mark RimerDirector
  • Robert M. PatzigDirector
  • Samuel D. RiccitelliDirector
  • Michael A. LutherDirector
  • Ilan DanieliExecutive Officer, Director
Offering amount
$400K
Amount sold
$400K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedApr 2017 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert M PatzigDirector
  • Paul KinnonExecutive Officer, Director
  • Doit L KopplerDirector
  • Mya ThomaeDirector
  • Michael LutherDirector
Offering amount
$1.3M
Amount sold
$1.1M
Sales commissions
$84K
Placement agents
Aegis Capital Corp.
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJan 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert M. PatzigDirector
  • Doit L. Koppler, IIDirector
  • Michael LutherDirector
  • Paul KinnonExecutive Officer, Director
  • Mya ThomaeDirector
  • Leon F. RichardsExecutive Officer
Offering amount
$2.2M
Amount sold
$2.2M
Sales commissions
$140K
Placement agents
Craig-Hallum Capital Group LLC
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJul 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul KinnonExecutive Officer, Director
  • John D. ThompsonDirector
  • Michael A. LutherDirector
  • Doit L. Koppler, IIDirector
  • Leon F. RichardsExecutive Officer
  • Robert M. PatzigDirector
  • Mya ThomaeDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$212.8K
Placement agents
Craig-Hallum Capital Group LLC
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Transgenomic do?
Transgenomic was a molecular diagnostics company that developed genetic testing platforms like WAVE and ICE COLD-PCR for cancer and inherited disease detection, and ran CLIA-certified labs.
Who are Transgenomic's investors?
Transgenomic's investors include Sofinnova Ventures.
How much funding has Transgenomic raised?
Transgenomic has disclosed $52.7M raised across 12 of its 13 known rounds.
Where is Transgenomic headquartered?
Transgenomic is headquartered in Omaha, US.